Dune Medical Devices
Dune Medical Devices was founded to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the ability to detect cancer in real time, this technology holds promise for a broad range of diagnostic and therapeutic applications.
The company’s first offering, the MarginProbe® System, is being used routinely to deliver real-time assessment on excised tissue in breast cancer surgery. The initial 300-patient randomized study showed a reduction in reoperation rates by 56% over the standard of care. To date, over 1500 patients have been involved in pre and post market studies showing similar results. Dune Medical Devices is a privately held company with offices in the US and Israel.